China-based CARsgen Therapeutics, a company focused on developing innovative CAR T-cell therapies, has announced that as...
ChemT Biotechnology, an AI-driven biotechnology startup in Singapore building the intelligence layer for biomanufacturin...
The COVID-19 pandemic demonstrated that scientific discovery can move at extraordinary speed, but it also expose...
Despite decades of advances in oncology, many solid tumours remain difficult to treat effectively without exposing patie...
The RNA revolution is entering a new chapter. While mRNA transformed the industry's perception of nucleic acid therapeut...
After several years of volatility, biotechnology financing has returned—but under very different rules. Investors ...
As biotechnology enters an increasingly data-driven era, organisations are rethinking how discovery, clinical developmen...
As biologics and cell and gene therapies continue to advance, manufacturing infrastructure is emerging as a critical det...
As biotechnology enters a new phase of disciplined investment and precision-driven innovation, leaders who can bridge sc...
Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, today announced ...
When the BIO International Convention opens in San Diego on 22 June, the Italian National Pavilion will arrive carrying ...
Griffith University and Nucleus Network, both in Australia, have signed a Memorandum of Understanding (MoU) that establi...
As life sciences laboratories embrace automation, digitalisation, and increasingly complex research workflows, technolog...
In a step that reflects Abu Dhabi’s growing contribution to global health security, the Abu Dhabi Public Health Ce...
When the global biotech community converges on the San Diego Convention Center this June, it does so in a market still f...
StemSight, a Finnish biotechnology startup developing off-the-shelf regenerative cell therapies for curing blindness, ha...
As industries seek more sustainable ways to produce ingredients, chemicals and materials, synthetic biology is opening u...
A research team led by Hong Kong Baptist University (HKBU) has discovered that extracts from the Justicia Chin...
Rznomics has presented interim Phase 1/2a clinical data for RZ-001, its RNA editing-based anticancer gene therapy for re...
Inflammatory bowel disease is becoming a growing focus within immunology innovation across Asia-Pacific, as the region s...
South Korea-based OliX Pharmaceuticals, a leading developer of RNAi therapeutics, has raised approximately KRW 110 ...
SCbio will spotlight South Carolina’s expanding life sciences sector at BIO International Convention 2026 in San D...
China-based Simcere Pharmaceutical Group has entered into a research collaboration agreement with Stanford Medicine, US ...
Japan's Lotte Holdings has announced an investment in ClearideBio Therapeutics AG, an early-stage biotechnology sta...
MaaT Pharma has presented final Phase 3 data from the ARES pivotal trial evaluating MaaT013 in acute graft-versus-host d...
